Bessemer Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $154M | Buy |
579,036
+185,847
| +47% | +$50.3M | 0.24% | 102 |
|
|
2025
Q4 | $98.6M | Buy |
393,189
+209,947
| +115% | +$55.8M | 0.15% | 151 |
|
|
2025
Q3 | $52.6M | Buy |
183,242
+178,681
| +3,918% | +$47.9M | 0.08% | 186 |
|
|
2025
Q2 | $1.2M | Sell |
4,561
-687
| -13% | -$167K | ﹤0.01% | 585 |
|
|
2025
Q1 | $1.22M | Buy |
5,248
+1,765
| +51% | +$428K | ﹤0.01% | 626 |
|
|
2024
Q4 | $799K | Buy |
3,483
+2,603
| +296% | +$597K | ﹤0.01% | 802 |
|
|
2024
Q3 | $197K | Buy |
880
+35
| +4% | +$7.69K | ﹤0.01% | 1120 |
|
|
2024
Q2 | $172K | Sell |
845
-415
| -33% | -$84.4K | ﹤0.01% | 1036 |
|
|
2024
Q1 | $276K | Sell |
1,260
-69
| -5% | -$15.2K | ﹤0.01% | 943 |
|
|
2023
Q4 | $302K | Sell |
1,329
-122
| -8% | -$25.6K | ﹤0.01% | 948 |
|
|
2023
Q3 | $291K | Sell |
1,451
-816
| -36% | -$172K | ﹤0.01% | 945 |
|
|
2023
Q2 | $470K | Sell |
2,267
-297,182
| -99% | -$57.7M | ﹤0.01% | 841 |
|
|
2023
Q1 | $59M | Sell |
299,449
-129,015
| -30% | -$26.5M | 0.14% | 166 |
|
|
2022
Q4 | $86.7M | Sell |
428,464
-6,042
| -1% | -$1.18M | 0.21% | 137 |
|
|
2022
Q3 | $76.5M | Sell |
434,506
-96,989
| -18% | -$19.9M | 0.2% | 139 |
|
|
2022
Q2 | $107M | Sell |
531,495
-92,493
| -15% | -$19.7M | 0.27% | 115 |
|
|
2022
Q1 | $141M | Buy |
623,988
+14,131
| +2% | +$3.32M | 0.3% | 105 |
|
|
2021
Q4 | $165M | Buy |
609,857
+14,641
| +2% | +$3.62M | 0.33% | 95 |
|
|
2021
Q3 | $144M | Sell |
595,216
-85,553
| -13% | -$21.6M | 0.31% | 102 |
|
|
2021
Q2 | $161M | Sell |
680,769
-136,262
| -17% | -$31M | 0.35% | 83 |
|
|
2021
Q1 | $179M | Sell |
817,031
-62,004
| -7% | -$12.4M | 0.43% | 63 |
|
|
2020
Q4 | $154M | Sell |
879,035
-57,665
| -6% | -$9.96M | 0.4% | 74 |
|
|
2020
Q3 | $152M | Sell |
936,700
-3,423
| -0.4% | -$542K | 0.45% | 63 |
|
|
2020
Q2 | $134M | Buy |
940,123
+200,136
| +27% | +$27.7M | 0.42% | 61 |
|
|
2020
Q1 | $80.3M | Buy |
739,987
+199,550
| +37% | +$28.8M | 0.32% | 90 |
|
|
2019
Q4 | $78.5M | Buy |
540,437
+4,188
| +0.8% | +$605K | 0.25% | 110 |
|
|
2019
Q3 | $77.4M | Sell |
536,249
-79,685
| -13% | -$11.6M | 0.28% | 110 |
|
|
2019
Q2 | $91.5M | Sell |
615,934
-216,666
| -26% | -$30.2M | 0.31% | 100 |
|
|
2019
Q1 | $109M | Buy |
832,600
+19,147
| +2% | +$2.36M | 0.42% | 83 |
|
|
2018
Q4 | $88.3M | Sell |
813,453
-225,848
| -22% | -$30.3M | 0.38% | 84 |
|
|
2018
Q3 | $155M | Sell |
1,039,301
-256,645
| -20% | -$39M | 0.58% | 61 |
|
|
2018
Q2 | $200M | Buy |
1,295,946
+15,473
| +1% | +$2.34M | 0.78% | 48 |
|
|
2018
Q1 | $178M | Buy |
1,280,473
+25,740
| +2% | +$3.78M | 0.69% | 54 |
|
|
2017
Q4 | $172M | Sell |
1,254,733
-71,508
| -5% | -$9.45M | 0.67% | 59 |
|
|
2017
Q3 | $172M | Sell |
1,326,241
-173,011
| -12% | -$23.1M | 0.69% | 56 |
|
|
2017
Q2 | $199M | Buy |
1,499,252
+455,293
| +44% | +$55.8M | 0.8% | 40 |
|
|
2017
Q1 | $129M | Buy |
1,043,959
+67,965
| +7% | +$8.05M | 0.54% | 65 |
|
|
2016
Q4 | $108M | Sell |
975,994
-18,694
| -2% | -$2.08M | 0.5% | 75 |
|
|
2016
Q3 | $117M | Buy |
994,688
+4,621
| +0.5% | +$545K | 0.59% | 60 |
|
|
2016
Q2 | $111M | Buy |
990,067
+366,951
| +59% | +$39.5M | 0.61% | 53 |
|
|
2016
Q1 | $62.7M | Buy |
623,116
+621,786
| +46,751% | +$59.6M | 0.35% | 104 |
|
|
2015
Q4 | $141K | Buy |
1,330
+379
| +40% | +$39.1K | ﹤0.01% | 785 |
|
|
2015
Q3 | $89K | Sell |
951
-7,773
| -89% | -$804K | ﹤0.01% | 855 |
|
|
2015
Q2 | $908K | Buy |
8,724
+28
| +0.3% | +$2.92K | ﹤0.01% | 553 |
|
|
2015
Q1 | $941K | Buy |
8,696
+2,410
| +38% | +$248K | ﹤0.01% | 525 |
|
|
2014
Q4 | $583K | Buy |
+6,286
| New | +$555K | ﹤0.01% | 564 |
|
|
2014
Q3 | – | Sell |
-180
| Closed | -$16K | – | 1324 |
|
|
2014
Q2 | $16K | Buy |
+180
| New | +$15.6K | ﹤0.01% | 1050 |
|
|
2014
Q1 | – | Sell |
-233
| Closed | -$18K | – | 1340 |
|
|
2013
Q4 | $18K | Buy |
+233
| New | +$19.9K | ﹤0.01% | 1009 |
|
Other funds holding LH
VCM
VPM
Bessemer Group's LH Position: Q1 2026 in Review
Bessemer Group increased its Labcorp (LH) stake by 47% in Q1 2026, buying an estimated $50.3M and bringing the position to 579,036 shares worth $154M. The position accounts for 0.24% of the portfolio, ranked #102.
Bessemer Group first reported a position in LH in Q4 2013 and has held it in 48 quarters since. The position peaked at $200M in Q2 2018. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Bessemer Group held 579,036 shares of Labcorp worth $154M as of Q1 2026.
- Bessemer Group bought 185,847 Labcorp shares in Q1 2026, an estimated $50.3M.
- Labcorp made up 0.24% of Bessemer Group's portfolio in Q1 2026, its #102 holding.
- Bessemer Group first reported a position in Labcorp in Q4 2013 and has held it in 48 quarters since.
- Bessemer Group's Labcorp position peaked at $200M in Q2 2018.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.